Agios Pharmaceuticals, Inc. ( AGIO) - Stock Earnings
AGIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | -99.1 million USD | 20.7 million USD |
| 2026Q2 | -100.7 million USD | 44.7 million USD |
| 2026Q3 | -65.0 million USD | 55.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AGIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -352.1 million USD | 26.8 million USD |
| 2024 | 673.7 million USD | 36.5 million USD |
| 2025 | -412.8 million USD | 54.0 million USD |
| 2026 Est. | — | — |
AGIO
Price: $31.63
52 week price:
Earnings Per Share: -6.52 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 44002
Ebitda: -88.5 millionMarket Capitalization: 2.0 billion